Inequitable access to breast cancer services affects patient outcomes, especially for underserved groups. Improving screening rates is crucial to address these disparities, as early detection is key to appropriate referral for effective care and treatment.

In this session you will gain a deeper understanding of the relationship between health inequalities and breast cancer, learn about the community-led approaches to designing and delivering services, and understand the benefits of successful partnerships and collaborations between communities, the NHS, local government, private sectors and voluntary organisations to make services equitable for everybody.

This session is supported by Novartis UK